Literature DB >> 14734645

Apolipoprotein A-1 interaction with plasma membrane lipid rafts controls cholesterol export from macrophages.

Katharina Gaus1, Leonard Kritharides, Gerd Schmitz, Alfred Boettcher, Wolfgang Drobnik, Thomas Langmann, Carmel M Quinn, Alison Death, Roger T Dean, Wendy Jessup.   

Abstract

Cholesterol efflux to apolipoprotein A-1 (apoA-1) from cholesterol-loaded macrophages is an important anti-atherosclerotic mechanism in reverse cholesterol transport. We recently provided kinetic evidence for two distinct pathways for cholesterol efflux to apoA-1 [Gaus et al. (2001) Biochemistry 40, 9363]. Cholesterol efflux from two membrane pools occurs sequentially with different kinetics; a small pool rapidly effluxed over the first hour, followed by progressive release from a major, slow efflux pool over several hours. In the present study, we propose that the rapid and slow cholesterol efflux pools represent cholesterol derived from lipid raft and nonraft domains of the plasma membrane, respectively. We provide direct evidence that apoA-1 binds to both lipid raft and nonraft domains of the macrophage plasma membrane. Conditions that selectively deplete plasma membrane lipid raft cholesterol, such as incorporation of 7-ketocholesterol or rapid exposure to cyclodextrins, block apoA-1 binding to these domains but also inhibit cholesterol efflux from the major, slow pool. We propose that cholesterol exported to apoA-1 from this major slow efflux pool derives from nonraft regions of the plasma membrane but that the interaction of apoA-1 with lipid rafts is necessary to stimulate this efflux.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734645     DOI: 10.1096/fj.03-0486fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  27 in total

Review 1.  Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling.

Authors:  Michael B Fessler; John S Parks
Journal:  J Immunol       Date:  2011-08-15       Impact factor: 5.422

2.  Identification of Apolipoprotein A-I as a Retinoic Acid-binding Protein in the Eye.

Authors:  Jody A Summers; Angelica R Harper; Christa L Feasley; Hanke Van-Der-Wel; Jennifer N Byrum; Marcela Hermann; Christopher M West
Journal:  J Biol Chem       Date:  2016-07-11       Impact factor: 5.157

3.  Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages.

Authors:  Lesley E Smythies; C Roger White; Akhil Maheshwari; M N Palgunachari; G M Anantharamaiah; Manjula Chaddha; Ashish R Kurundkar; Geeta Datta
Journal:  Am J Physiol Cell Physiol       Date:  2010-03-10       Impact factor: 4.249

Review 4.  Anti-atherogenic mechanisms of high density lipoprotein: effects on myeloid cells.

Authors:  Andrew J Murphy; Marit Westerterp; Laurent Yvan-Charvet; Alan R Tall
Journal:  Biochim Biophys Acta       Date:  2011-08-16

5.  CD36-dependent 7-ketocholesterol accumulation in macrophages mediates progression of atherosclerosis in response to chronic air pollution exposure.

Authors:  Xiaoquan Rao; Jixin Zhong; Andrei Maiseyeu; Bhavani Gopalakrishnan; Frederick A Villamena; Lung-Chi Chen; Jack R Harkema; Qinghua Sun; Sanjay Rajagopalan
Journal:  Circ Res       Date:  2014-09-03       Impact factor: 17.367

6.  Biochemical and structural characterization of apolipoprotein A-I binding protein, a novel phosphoprotein with a potential role in sperm capacitation.

Authors:  Kula N Jha; Igor A Shumilin; Laura C Digilio; Olga Chertihin; Heping Zheng; Gerd Schmitz; Pablo E Visconti; Charles J Flickinger; Wladek Minor; John C Herr
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

Review 7.  High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy.

Authors:  S-H Wang; S-G Yuan; D-Q Peng; S-P Zhao
Journal:  Clin Exp Immunol       Date:  2010-01-06       Impact factor: 4.330

8.  Protein extraction and 2-DE of water- and lipid-soluble proteins from bovine pericardium, a low-cellularity tissue.

Authors:  Leigh G Griffiths; Leila Choe; Kelvin H Lee; Kenneth F Reardon; E Christopher Orton
Journal:  Electrophoresis       Date:  2008-11       Impact factor: 3.535

Review 9.  Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies.

Authors:  Raphael Zidovetzki; Irena Levitan
Journal:  Biochim Biophys Acta       Date:  2007-04-06

10.  Cholesterol is a determinant of the structures of discoidal high density lipoproteins formed by the solubilization of phospholipid membranes by apolipoprotein A-I.

Authors:  John B Massey; Henry J Pownall
Journal:  Biochim Biophys Acta       Date:  2008-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.